AP549A - Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. - Google Patents
Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. Download PDFInfo
- Publication number
- AP549A AP549A APAP/P/1992/000356A AP9200356A AP549A AP 549 A AP549 A AP 549A AP 9200356 A AP9200356 A AP 9200356A AP 549 A AP549 A AP 549A
- Authority
- AP
- ARIPO
- Prior art keywords
- quinone
- composition
- acid
- formula
- concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
- C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
- C09B67/0034—Mixtures of two or more pigments or dyes of the same type
- C09B67/0038—Mixtures of anthraquinones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103075A GB9103075D0 (en) | 1991-02-13 | 1991-02-13 | Trinitrobenzene derivatives and their therapeutic use |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9200356A0 AP9200356A0 (en) | 1992-04-30 |
AP549A true AP549A (en) | 1996-11-01 |
Family
ID=10689992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1992/000356A AP549A (en) | 1991-02-13 | 1992-02-12 | Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0499467A3 (no) |
JP (1) | JPH06505231A (no) |
CN (1) | CN1064407A (no) |
AP (1) | AP549A (no) |
AU (2) | AU1233992A (no) |
BG (1) | BG61025B1 (no) |
BR (1) | BR9205642A (no) |
CA (1) | CA2104009A1 (no) |
CZ (1) | CZ166893A3 (no) |
DZ (1) | DZ1559A1 (no) |
FI (1) | FI933595A (no) |
GB (2) | GB9103075D0 (no) |
GT (1) | GT199200009A (no) |
HU (1) | HUT65634A (no) |
IE (1) | IE920464A1 (no) |
IL (1) | IL100906A (no) |
IN (1) | IN178929B (no) |
IS (1) | IS3814A (no) |
JO (1) | JO1719B1 (no) |
LT (1) | LT3197B (no) |
MA (1) | MA22443A1 (no) |
MX (1) | MX9200622A (no) |
MY (1) | MY131098A (no) |
NO (1) | NO932681L (no) |
NZ (2) | NZ240487A (no) |
OA (2) | OA09535A (no) |
SK (1) | SK87993A3 (no) |
TN (1) | TNSN92015A1 (no) |
WO (1) | WO1992014454A1 (no) |
ZA (1) | ZA921037B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9103075D0 (en) | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
DZ1781A1 (fr) * | 1993-05-21 | 2002-02-17 | Radopah Ltd | Agents d'arylation. |
BR9507128A (pt) * | 1994-03-17 | 1997-09-30 | Radopath Ltd | Composto e composição farmacêutica para tratamento de profilaxia ou terapia de neoplasma ou infecção viral ácido 2- cloro-5-nitrobenzóico processo de preparação de composição farmacêutica processo de tratamento por frofilaxia ou terapia de neoplasma ou infecção viral e processo de tratamento de mamíferos para profilaxia de sarcoma de kaposi |
EP0705601B1 (de) * | 1994-10-04 | 2000-01-19 | LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik | Lösungen von Anthrachinonen zur parenteralen Applikation |
US7482029B2 (en) | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
US7537774B2 (en) * | 2005-12-23 | 2009-05-26 | Orion Therapeautics, Llc | Therapeutic formulation |
US8092841B2 (en) | 2007-08-08 | 2012-01-10 | Bionovo, Inc. | Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof |
JP2010538093A (ja) | 2007-09-07 | 2010-12-09 | バイオノボ・インコーポレーテッド | シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用 |
AU2008296072A1 (en) | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof |
EP2194998A4 (en) | 2007-09-07 | 2012-03-21 | Bionovo Inc | STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF |
EP2060562A1 (en) * | 2007-11-16 | 2009-05-20 | Laboratoire Medidom S.A. | Dioxoanthracene sulphonate derivatives |
EP2222323A4 (en) | 2007-11-19 | 2012-07-25 | Bionovo Inc | PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON |
AU2008326426A1 (en) | 2007-11-19 | 2009-05-28 | Bionovo, Inc. | Methods of detecting and treatment of cancers using scuttelaria barbata extract |
CA2727018A1 (en) * | 2008-06-06 | 2009-12-10 | Bionovo, Inc. | Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions |
US9884815B2 (en) * | 2011-10-14 | 2018-02-06 | Emory University | PGAM1 inhibitors and methods related thereto |
CZ304335B6 (cs) * | 2012-02-22 | 2014-03-12 | Mikrobiologický ústav AV ČR, v. v. i. | Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití |
KR20210032405A (ko) * | 2018-07-17 | 2021-03-24 | 삘리 | 안트라퀴논 유도체 및 착색제로서의 그의 용도 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5643210A (en) * | 1979-09-18 | 1981-04-21 | Koutaku Hayashi | Immunity enhancing, drug resistance preventive and carcinostatic agent |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA774443B (en) * | 1977-07-22 | 1978-06-28 | Allied Chem | Anthrquinone compounds as anti-cancer agents |
JPS6043210A (ja) * | 1983-08-18 | 1985-03-07 | Tdk Corp | 磁気ヘツド及びその製造方法 |
DE3431236A1 (de) * | 1984-08-24 | 1986-02-27 | Carnivora-Deutschland GmbH, 7109 Jagsthausen | Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation |
DE3601065A1 (de) * | 1986-01-16 | 1987-07-23 | Behringwerke Ag | Chinon-derivate als antitumormittel |
WO1989005141A1 (en) * | 1987-12-10 | 1989-06-15 | Tsumura Juntendo, Inc. | Anti-retroviral drug |
HU208624B (en) * | 1988-08-16 | 1993-12-28 | Wellcome Found | Process for producing pharmaceutical compositions containing naphtoquinone derivatives effective against pneumocystis infections |
GB9103075D0 (en) | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
EP0524212A1 (en) * | 1990-04-03 | 1993-01-27 | Radopath Limited | Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
DE4013023A1 (de) * | 1990-04-24 | 1991-11-07 | Lohmann Rudolf Lomapharm | Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen |
-
1991
- 1991-02-13 GB GB919103075A patent/GB9103075D0/en active Pending
- 1991-11-05 NZ NZ240487A patent/NZ240487A/en unknown
-
1992
- 1992-02-10 IN IN97DE1992 patent/IN178929B/en unknown
- 1992-02-10 IL IL10090692A patent/IL100906A/en not_active IP Right Cessation
- 1992-02-11 NZ NZ241593A patent/NZ241593A/en unknown
- 1992-02-12 AP APAP/P/1992/000356A patent/AP549A/en active
- 1992-02-12 DZ DZ920016A patent/DZ1559A1/fr active
- 1992-02-12 IS IS3814A patent/IS3814A/is unknown
- 1992-02-12 MA MA22730A patent/MA22443A1/fr unknown
- 1992-02-13 BR BR9205642A patent/BR9205642A/pt not_active Application Discontinuation
- 1992-02-13 GB GB9203084A patent/GB2254554B/en not_active Expired - Fee Related
- 1992-02-13 CA CA002104009A patent/CA2104009A1/en not_active Abandoned
- 1992-02-13 TN TNTNSN92015A patent/TNSN92015A1/fr unknown
- 1992-02-13 CN CN92100817A patent/CN1064407A/zh active Pending
- 1992-02-13 CZ CS931668A patent/CZ166893A3/cs unknown
- 1992-02-13 EP EP19920301185 patent/EP0499467A3/en not_active Withdrawn
- 1992-02-13 HU HU9302347A patent/HUT65634A/hu unknown
- 1992-02-13 ZA ZA921037A patent/ZA921037B/xx unknown
- 1992-02-13 MY MYPI92000228A patent/MY131098A/en unknown
- 1992-02-13 SK SK879-93A patent/SK87993A3/sk unknown
- 1992-02-13 OA OA60150A patent/OA09535A/en unknown
- 1992-02-13 AU AU12339/92A patent/AU1233992A/en not_active Abandoned
- 1992-02-13 JP JP4504180A patent/JPH06505231A/ja active Pending
- 1992-02-13 JO JO19921719A patent/JO1719B1/en active
- 1992-02-13 IE IE046492A patent/IE920464A1/en unknown
- 1992-02-13 MX MX9200622A patent/MX9200622A/es not_active Application Discontinuation
- 1992-02-13 WO PCT/GB1992/000262 patent/WO1992014454A1/en not_active Application Discontinuation
- 1992-02-13 GT GT199200009A patent/GT199200009A/es unknown
-
1993
- 1993-02-05 LT LTIP329A patent/LT3197B/lt not_active IP Right Cessation
- 1993-07-26 NO NO93932681A patent/NO932681L/no unknown
- 1993-08-13 FI FI933595A patent/FI933595A/fi not_active Application Discontinuation
- 1993-08-13 OA OA60399A patent/OA09810A/en unknown
- 1993-08-13 BG BG98041A patent/BG61025B1/bg unknown
-
1996
- 1996-06-11 AU AU55906/96A patent/AU5590696A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5643210A (en) * | 1979-09-18 | 1981-04-21 | Koutaku Hayashi | Immunity enhancing, drug resistance preventive and carcinostatic agent |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP549A (en) | Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections. | |
AU2001230977B2 (en) | Combinations for treating neoplasms | |
Schultz | Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney | |
AU2001230977A1 (en) | Combinations for treating neoplasms | |
BG63612B1 (bg) | Състав и метод за профилактика и лечение на нiv идруги инфекциозни заболявания при човека | |
Hellmann et al. | Preliminary clinical assessment of ICRF 159 in acute leukaemia and lymphosarcoma | |
Strommen et al. | Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment | |
JP2011516478A (ja) | 免疫療法のための組成物および方法 | |
EP0281380A2 (en) | Synergistic interplay of interleukin-2 and dsRNAs | |
US6720011B1 (en) | Injectable composition for cancer treatment | |
AU662883B2 (en) | Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases | |
OA12862A (en) | Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone. | |
JP2020537689A (ja) | A−ノル−5αアンドロスタン化合物を含む白血球増多製剤およびその使用 | |
Desimone et al. | Tetrahydrouridine, cytidine analogues, and hemoglobin F | |
HRP920891A2 (en) | Quinone preparation | |
AU651998B2 (en) | Use of a retinoid | |
KR102576410B1 (ko) | 바실러스 균주와 5-fu를 유효성분으로 하는 대장암 치료용 약학 조성물 | |
Slevin et al. | The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension | |
EP0874630A1 (en) | Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy | |
KR20020026743A (ko) | 비소화합물 및 글루타치온 고갈 유도 화합물을 함유하는항암조성물 | |
CN117243963A (zh) | Remodelin与Venetoclax在治疗癌症中的应用 | |
JPH05221868A (ja) | 食細胞貪食能賦活剤 | |
CZ2014517A3 (cs) | Farmaceutický prostředek s virucidním a antibakteriálním účinkem | |
MXPA97000190A (en) | Chemioprevention of colorectal polipos adenomatosos metacrono |